Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome — Six States, 2013–2017

Morbidity and Mortality Weekly Report

Volumn 68, Issue 1, 2019, Pages 6-10

  Jilani, Shahla M ^a   Frey, Meghan T ^b   Pepin, Dawn ^c,d   Jewell, Tracey ^e   Jordan, Melissa ^f   Miller, Angela M ^g   Robinson, Meagan ^h   Mars, Tomi St ⁱ   Bryan, Michael ^j   Ko, Jean Y ^k   Ailes, Elizabeth C ^b   McCord, Russell F ^b,l   Gilchrist, Julie ^m   Foster, Sarah ^a   Lind, Jennifer N ^b   Culp, Lindsay ⁿ   Penn, Matthew S ^d   Reefhuis, Jennita ^b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c Cherokee Nation Assurance   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Kentucky Department for Public Health   (United States)

^f FLORIDA DEPARTMENT OF HEALTH   (United States)

^g Tennessee State Department of Health   (United States)

^h VIRGINIA DEPARTMENT OF HEALTH   (United States)

ⁱ Arizona State Department of Health   (United States)

^j Georgia Department of Public Health   (United States)

^k NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^l OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^m Carter Consulting Inc   (United States)

ⁿ NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EVALUATION STUDY; HEALTH SURVEY; HUMAN; MANDATORY REPORTING; NEONATAL ABSTINENCE SYNDROME; UNITED STATES;

HUMANS; MANDATORY REPORTING; NEONATAL ABSTINENCE SYNDROME; PUBLIC HEALTH SURVEILLANCE; UNITED STATES;

EID: 85059828250     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/MMWR.MM6801A2     Document Type: Article

References (9)

1. Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid. Pediatrics 2018;141:e2017-3520. https://doi.org/10.1542/peds.2017-3520
2. Broussard CS, Rasmussen SA, Reefhuis J, et al.; National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011;204:314.e1-11. https://doi. org/10.1016/j.ajog.2010.12.039
3. Yazdy MM, Mitchell AA, Tinker SC, Parker SE, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol 2013;122:838-44. https://doi.org/10.1097/AOG.0b013e3182a6643c
4. Lind JN, Interrante JD, Ailes EC, et al. Maternal use of opioids during pregnancy and congenital malformations: A systematic review. Pediatrics 2017;139:e2016-4131. https://doi.org/10.1542/peds.2016-4131
5. Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes. Anesthesiology 2014;121:1158-65. https://doi.org/10.1097/ALN.0000000000000472
6. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev 2007;26:487-92. https://doi.org/10.1080/09595230701494416
7. CDC. Public health grand rounds: Surveillance for emerging threats to pregnant women and infants: Data for action. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www. cdc.gov/grand-rounds/pp/2018/20180918-pregnancy-threats.html
8. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: Assessment and management. Addict Dis 1975;2:141-58.
9. Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr (Phila) 1975;14:592-4. https://doi.org/10.1177/000992287501400613